Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Elizabeth C. Dee"'
Autor:
Yandong Qiang, Elizabeth C. Dee, Catherine A. Panozzo, Richard S. Swain, Christian Hampp, Casie Horgan, Judith C. Maro, Rong Chen Tilney, Sarah K. Dutcher, Andrew B. Petrone
Publikováno v:
Diabetes Care
OBJECTIVE To estimate real-world off-label use of sodium–glucose cotransporter 2 (SGLT2) inhibitors in patients with type 1 diabetes, estimate rates of diabetic ketoacidosis (DKA), and compare them with DKA rates observed in sotagliflozin clinical
Autor:
Justin Bohn, Adebola O. Ajao, Efe Eworuke, Casie Horgan, Lois La Grenade, Monica A. Muñoz, Veronica Sansing-Foster, Mohamed Mohamoud, Elizabeth C. Dee, Danijela Stojanovic, Oren Shapira
Publikováno v:
Pharmacotherapy
Background Cutaneous small vessel vasculitis (CSVV) has been reported after exposure to direct oral anticoagulants (DOACs), such as dabigatran, rivaroxaban, apixaban, and edoxaban. Objective We used the U.S. Food and Drug Administration Adverse Event
Autor:
Austin Cosgrove, Tancy Zhang, Tiffany S. Woodworth, Sruthi Adimadhyam, Marie C. Bradley, Hana Lee, Sengwee Toh, Nicole Haug, Efe Eworuke, Andrew B. Petrone, Elizabeth C. Dee
Publikováno v:
JNCI Cancer Spectr
Background European studies reported an increased risk of nonmelanoma skin cancer associated with hydrochlorothiazide (HCTZ)-containing products. We examined the risks of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) associated with HC
Autor:
Sengwee Toh, Efe Eworuke, Dinci Pennap, Noelle M. Cocoros, Andrew D. Mosholder, Elizabeth C. Dee, Veronica V. Sansing-Foster, Ella Pestine, Nicole Haug, Andrew B. Petrone, Ivone Kim, Yong Ma, Jennifer G. Lyons, Marie C. Bradley
Publikováno v:
The journal of allergy and clinical immunology. In practice. 9(1)
Background There have been conflicting results from observational studies regarding the risk of psychiatric adverse events (PAEs) with montelukast use. Objective To determine whether there are associations of depressive disorders, self-harm, and suic
Autor:
Elizabeth C. Dee, Jennifer Popovic, Marc R. Larochelle, Noelle M. Cocoros, Cynthia Kornegay, Jing Ju, Judith A. Racoosin
Publikováno v:
Journal of Opioid Management. 13:341-524
Objective: A risk evaluation and mitigation strategy for extended-release and long-acting (ER/LA) opioid analgesics was approved by the Food and Drug Administration in 2012. Our objective was to assess frequency of opioid tolerance and urine drug tes
Autor:
Marc R. Larochelle, MD, MPH, Noelle M. Cocoros, DSc, MPH, Jennifer Popovic, DVM, MA, Elizabeth C. Dee, MPH, Cynthia Kornegay, PhD, Jing Ju, PharmD, PhD, Judith A. Racoosin, MD, MPH
Publikováno v:
Journal of Opioid Management. 13:315-327
Objective: A risk evaluation and mitigation strategy for extended-release and long-acting (ER/LA) opioid analgesics was approved by the Food and Drug Administration in 2012. Our objective was to assess frequency of opioid tolerance and urine drug tes
Autor:
Efe Eworuke, Michael D. Blum, Elnara Fazio-Eynullayeva, Jennifer G. Lyons, Sengwee Toh, Amanda Carruth, Elizabeth C. Dee, Catherine A. Panozzo, Michael D. Nguyen, Sarah K. Dutcher
Publikováno v:
Pharmacoepidemiology and drug safetyREFERENCES. 29(7)
PURPOSE To describe utilization of filgrastim and infliximab, the first two products with biosimilars approved in the United States. METHODS We identified use of filgrastim (reference, tbo-filgrastim, and filgrastim-sndz) and infliximab (reference, i
Autor:
Qoua L. Her, Michael Nguyen, Elizabeth C. Dee, Chi-Ming Tu, Nancy D. Lin, Kevin Haynes, Austin Cosgrove, Noelle M. Cocoros, Yulan Ding, Sengwee Toh
Publikováno v:
Pharmacoepidemiology and drug safetyREFERENCES. 28(10)
Purpose In July 2015, the US Food and Drug Administration (FDA) published a drug safety communication regarding errors in prescribing and dispensing of the antidepressant Brintellix (vortioxetine) and the antiplatelet Brilinta (ticagrelor) that arose
Autor:
Michael Klompas, Elizabeth C. Dee, Elizabeth Torrone, Ellen Hafer, John T. Menchaca, Bob Zambarano, Benjamin A. Kruskal, Mark E. Josephson, Brian Herrick, Michelle Weiss, Noelle M. Cocoros, Jessica G. Young, Katherine K. Hsu, Elaine W. Flagg, Diana Erani
Publikováno v:
American journal of preventive medicine. 56(3)
Introduction National guidelines recommend test-of-cure for pregnant women and test-of-reinfection for all patients with chlamydia infections in order to interrupt transmission and prevent adverse sequelae for patients, partners, and newborns. Little
Autor:
Eworuke, Efe, Haug, Nicole, Bradley, Marie, Cosgrove, Austin, Zhang, Tancy, Dee, Elizabeth C, Adimadhyam, Sruthi, Petrone, Andrew, Lee, Hana, Woodworth, Tiffany, Toh, Sengwee
Publikováno v:
JNCI Cancer Spectrum; Apr2021, Vol. 5 Issue 2, p1-8, 8p